已收录 268921 条政策
 政策提纲
  • 暂无提纲
Botulinum Toxin A for Refractory Neuropathic Pain in Supraorbital Postherpetic Neuralgia
[摘要] This case series assesses the benefits of intracutaneous injection of botulinum toxin A (BTX-A) for the treatment of intractable pain of supraorbital postherpetic neuralgia (PHN) not responding to oral drug therapy. Three patients experiencing intractable pain of supraorbital PHN, which was not responding satisfactorily to oral pregabalin and oral amitriptyline therapy, were managed with the intracutaneous injection of BTX-A in the affected dermatomes. Postinjection during each visit at 2, 4, 6, 8, 10, and 16 weeks, the Numeric Rating Scale pain score of the patients was assessed (0: painless; 10: maximum pain). There was a significant reduction in the severity of pain after BTX-A injection, and subsequently, the oral medications were significantly reduced thereafter. Hence, BTX significantly decreases the severity of intractable pain in supraorbital PHN patients.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 分子生物学,细胞生物学和基因
[关键词] Botulinum toxin;intractable pain;neuropathic pain;postherpetic neuralgia [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文